Vyant Bio, Inc.
VYNT
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 72.01% | 51.11% | 82.86% | 22.37% | -38.68% |
| Total Depreciation and Amortization | -57.97% | -19.58% | -54.27% | -33.56% | 158.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.88% | -97.07% | -96.66% | -45.20% | 196.20% |
| Change in Net Operating Assets | -99.01% | -486.21% | -71.01% | 233.50% | 91.98% |
| Cash from Operations | 56.55% | -41.21% | -9.62% | 32.11% | 31.59% |
| Capital Expenditure | -- | -- | 35.71% | -1,664.29% | 31.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -340.00% | 6,805.08% | -106.35% | 330.77% |
| Cash from Investing | 100.00% | 196.67% | 5,506.85% | -612.24% | 39.07% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -565.79% | -161.76% | -62.16% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 572.73% | 9.09% | -1,540.00% |
| Cash from Financing | -25.25% | 371.32% | -101.66% | 1,890.91% | -1,920.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.48% | -24.33% | 124.93% | 29.68% | 28.09% |